STAT3 activation is a key oncogenic pathway in human gastric cancer, particularly in intestinal-type tumors, where it promotes proliferation, angiogenesis, and immune evasion through IL-6 and IL-11 signaling (Qi et al., 2020; Wang YC. This evidence concerns the gene IL11 and gastric cancer.